日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Cobimetinib Plus Vemurafenib in Patients With Solid Tumors With BRAF Mutations: Results From the Targeted Agent and Profiling Utilization Registry Study

Cobimetinib 联合 Vemurafenib 治疗 BRAF 突变实体瘤患者:靶向药物及谱系分析应用注册研究的结果

Meric-Bernstam, Funda; Rothe, Michael; Mangat, Pam K; Garrett-Mayer, Elizabeth; Gutierrez, Rodolfo; Ahn, Eugene R; Cannon, Timothy L; Powell, Steven; Krauss, John C; Reynolds, Christopher M; von Mehren, Margaret; Behl, Deepti; Calfa, Carmen J; Duvivier, Herbert L; Kaplan, Henry G; Livingston, Michael B; Sharma, Manish R; Urba, Walter J; Grantham, Gina N; Hinshaw, Dominique C; Gregory, Abigail; Halabi, Susan; Schilsky, Richard L

A phase II trial of regorafenib in patients with advanced Ewing sarcoma and related tumors of soft tissue and bone: SARC024 trial results

瑞戈非尼治疗晚期尤文氏肉瘤及相关软组织和骨肿瘤患者的II期临床试验:SARC024试验结果

Attia, Steven; Bolejack, Vanessa; Ganjoo, Kristen N; George, Suzanne; Agulnik, Mark; Rushing, Daniel; Loggers, Elizabeth T; Livingston, Michael B; Wright, Jennifer; Chawla, Sant P; Okuno, Scott H; Reinke, Denise K; Riedel, Richard F; Davis, Lara E; Ryan, Christopher W; Maki, Robert G

Genomic alterations and clinical outcomes in patients with dedifferentiated liposarcoma

去分化脂肪肉瘤患者的基因组改变和临床结局

Jagosky, Megan H; Anderson, Colin J; Symanowski, James T; Steuerwald, Nury M; Farhangfar, Carol J; Baldrige, Emily A; Benbow, Jennifer H; Livingston, Michael B; Patt, Joshua C; Ahrens, Will A; Kneisl, Jeffrey S; Kim, Edward S

A Randomized, Double-Blind, Placebo-Controlled, Phase II Study of Regorafenib Versus Placebo in Advanced/Metastatic, Treatment-Refractory Liposarcoma: Results from the SARC024 Study

瑞戈非尼与安慰剂治疗晚期/转移性难治性脂肪肉瘤的随机、双盲、安慰剂对照 II 期研究:SARC024 研究结果

Riedel, Richard F; Ballman, Karla V; Lu, Yao; Attia, Steven; Loggers, Elizabeth T; Ganjoo, Kristen N; Livingston, Michael B; Chow, Warren; Wright, Jennifer; Ward, John H; Rushing, Daniel; Okuno, Scott H; Reed, Damon R; Liebner, David A; Keedy, Vicki L; Mascarenhas, Leo; Davis, Lara E; Ryan, Christopher; Reinke, Denise K; Maki, Robert G

Randomized Double-Blind Phase II Study of Regorafenib in Patients With Metastatic Osteosarcoma

瑞戈非尼治疗转移性骨肉瘤患者的随机双盲II期研究

Davis, Lara E; Bolejack, Vanessa; Ryan, Christopher W; Ganjoo, Kristen N; Loggers, Elizabeth T; Chawla, Sant; Agulnik, Mark; Livingston, Michael B; Reed, Damon; Keedy, Vicky; Rushing, Daniel; Okuno, Scott; Reinke, Denise K; Riedel, Richard F; Attia, Steven; Mascarenhas, Leo; Maki, Robert G

Olaratumab and doxorubicin versus doxorubicin alone for treatment of soft-tissue sarcoma: an open-label phase 1b and randomised phase 2 trial

Olaratumab联合多柔比星对比单用多柔比星治疗软组织肉瘤:一项开放标签的1b期和随机2期试验

Tap, William D; Jones, Robin L; Van Tine, Brian A; Chmielowski, Bartosz; Elias, Anthony D; Adkins, Douglas; Agulnik, Mark; Cooney, Matthew M; Livingston, Michael B; Pennock, Gregory; Hameed, Meera R; Shah, Gaurav D; Qin, Amy; Shahir, Ashwin; Cronier, Damien M; Ilaria, Robert Jr; Conti, Ilaria; Cosaert, Jan; Schwartz, Gary K

Cixutumumab and temsirolimus for patients with bone and soft-tissue sarcoma: a multicentre, open-label, phase 2 trial.

Cixutumumab 和 temsirolimus 治疗骨和软组织肉瘤患者:一项多中心、开放标签的 2 期试验

Schwartz Gary K, Tap William D, Qin Li-Xuan, Livingston Michael B, Undevia Samir D, Chmielowski Bartosz, Agulnik Mark, Schuetze Scott M, Reed Damon R, Okuno Scott H, Ludwig Joseph A, Keedy Vicki, Rietschel Petra, Kraft Andrew S, Adkins Douglas, Van Tine Brian A, Brockstein Bruce, Yim Vincent, Bitas Christiana, Abdullah Abdul, Antonescu Cristina R, Condy Mercedes, Dickson Mark A, Vasudeva Shyamprasad Deraje, Ho Alan L, Doyle L Austin, Chen Helen X, Maki Robert G

Phase II study of sorafenib in patients with metastatic or recurrent sarcomas

索拉非尼治疗转移性或复发性肉瘤患者的II期研究

Maki, Robert G; D'Adamo, David R; Keohan, Mary L; Saulle, Michael; Schuetze, Scott M; Undevia, Samir D; Livingston, Michael B; Cooney, Matthew M; Hensley, Martee L; Mita, Monica M; Takimoto, Chris H; Kraft, Andrew S; Elias, Anthony D; Brockstein, Bruce; Blachère, Nathalie E; Edgar, Mark A; Schwartz, Lawrence H; Qin, Li-Xuan; Antonescu, Cristina R; Schwartz, Gary K